Ofatumumab
Products in Health Canada’s databases that list Ofatumumab as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 4
- 2 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 10
- Products in all
- 4
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| KESIMPTA (20 MG) | 02511355 | Marketed | Novartis Pharmaceuticals Canada Inc. | |
| KESIMPTA (20 MG) | 02511363 | Approved | Novartis Pharmaceuticals Canada Inc. | |
| ARZERRA (100 MG) | 02381559 | Cancelled Post Market | Novartis Pharmaceuticals Canada Inc. | |
| ARZERRA (1000 MG) | 02381567 | Cancelled Post Market | Novartis Pharmaceuticals Canada Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- KESIMPTAAugust 4, 2026 · NOC 38037
- KESIMPTAOctober 14, 2025 · NOC 36157
- KESIMPTAMarch 13, 2024 · NOC 32876
- KESIMPTAFebruary 12, 2024 · NOC 32785
- KESIMPTAJanuary 22, 2021 · NOC 25064
- ARZERRAJanuary 17, 2017 · NOC 18880
- ARZERRAAugust 6, 2015 · NOC 17180
- ARZERRAOctober 2, 2014 · NOC 16153
- ARZERRAMay 10, 2013 · NOC 14358
- ARZERRAMarch 9, 2012 · NOC 13090